Piramal Imaging Applauds Interim Results and Reiterates Support of IDEAS Trial in Mild Cognitive Impairment (MCI) and Atypical Dementia at AAIC
Read more >
What is Molecular Imaging?
Molecular imaging is a way to see what’s happening inside the body at the molecular and cellular level. Unlike x-rays, computed tomography (CT), ultrasound, and other diagnostic imaging procedures that predominantly offer anatomical pictures, molecular imaging allows physicians to see how the body is functioning and to measure its chemical and biological processes. Read more >
How does molecular imaging work?
When disease occurs, the biochemical activity of cells begins to change. This abnormal cellular activity begins to affect body tissue and structures, causing anatomical change that may be seen on CT or MRI scans.
Molecular imaging can detect these cellular changes that occur early in the course of the disease—often well before the structural changes that can be seen on CT or MR images. Read more >
What is the Value of Molecular Imaging?
Unlike x-rays, computed tomography (CT), magnetic resonance imaging, or ultrasound — which mostly show anatomical pictures — molecular imaging, using positron emission tomography (PET), allows physicians to see how the body is functioning and to measure its chemical and biological processes. This gives them a much greater understanding into a patient’s condition, which, in turn, can enable early detection and/or identification of changes occurring in tissue. Read more >
Next-Generation Tau PET Traceers Strut Their Stuff
Read more >
Piramal Imaging SA is an emerging leader in the field of molecular imaging. With a state-of-the-art research and development facility in Berlin Germany, and a US commercial subsidiary in Boston, Massachusetts, Piramal Imaging is dedicated to the development and global commercialization of innovative molecular imaging agents.
At Piramal Imaging we are providing innovative diagnostic imaging solutions to reduce the burden of disease.
We invite you to learn more about us.